Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02189642 · ClinicalTrials.gov registry record
Boston Children's Hospital Post Anesthesia Care Unit Outcomes Study
A clinical trial, sponsored by Boston Children's Hospital.
- Completed
- Registry status
- 643
- Enrollment target
NCT02189642: Completed study, sponsored by Boston Children's Hospital.
NCT02189642 is a clinical trial that has completed, run by Boston Children's Hospital. The registered enrollment target is 643 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02189642 has completed, sponsored by Boston Children's Hospital.
- COMPLETED
- Registry status
- 643 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the quality of outcomes in the Post Anesthesia Care Unit (PACU) at BCH and to identify preoperative demographic and behavioral data as well as intraoperative and anesthetic predictors of adverse PACU outcomes. The investigators hypothesize quality of PACU outcomes will correlate with preoperative demographic and behavioral characteristics as well as intraoperative and anesthetic procedures/techniques. This study will help the investigators improve post anesthetic care quality and create a higher level of satisfaction for patients, family, and health care providers.
Primary Outcome
Incidence of significant pain defined by pain behavior information from the Faces-Legs-Activity-Cry-Consolability (FLACC) scale, Wong-Baker Faces scale, visual analog scale/numerical scale or adapted numerical rating scale - equal to or more than 5 on a scale from 0 to 10 at any time during the PACU stay.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 643 participants |
| Start Date | 2013-07-13 |
| Est. Completion | 2017-03-08 |
What the finished NCT02189642 record still lists
NCT02189642 is an observational study that tracks outcomes without assigning an intervention. The registered 643 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02189642 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02189642 about?
NCT02189642 is a clinical study titled "Boston Children's Hospital Post Anesthesia Care Unit Outcomes Study". The purpose of this study is to evaluate the quality of outcomes in the Post Anesthesia Care Unit (PACU) at BCH and to identify preoperative demographic and behavioral data as well as intraoperative and anesthetic predictors of adverse PACU outcomes. The investigators hypothesize quality of PACU out...
What is the current status of trial NCT02189642?
This trial is currently completed. The enrollment target is 643 participants. The study started on 2013-07-13. Estimated completion is 2017-03-08.
Who is sponsoring clinical trial NCT02189642?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05146297 · 644 participants · NA
Diversity and Inclusion in Research Underpinning Prevention and Therapy Trials
- NCT06994442 · 644 participants · Phase 3
Optimizing Pain Treatment in Children On Mechanical Ventilation
- NCT05204888 · 642 participants · NA
myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
- NCT07012395 · 645 participants · Phase 2
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI